Patent Infringement: HC Orders Triveni Chemicals To Pay Rs 2 Cr To Pfizer

The recently asked a private company to pay Rs 2 crore in damages to pharmaceutical company for infringement.

Inc. and its group had filed a suit in the court against Triveni Interchem Private Limited & others accusing the latter for infringing their patent(IN 218291) for the compound Palbociclib.

The private entities(Triveni entities) were found to advertise and offer for sale generic Palbociclib in API form on their own websites and on IndiaMART (e-commerce platform), without any permission or authorisation from Pfizer, Advocates Pravin Anand along with Tusha Malhotra and Richa Bhargava, who were representing told the court.

The High Court had on October 21, 2021 granted an injunction in favour of Pfizer but the pharma company said they had found that the private entities had not stopped the sale of the compound Palbociclib. It claimed it had found that the entities were selling the same compound in a new packaging and through another channel.

Pfizer filed a contempt application against the activities of the Triveni entities and the High Court on July 7, 2022 observed that Triveni entities were in contempt of the injunction order.

Even after this, the infringing products were still found to be available on Connect2India (e-commerce platform), Pfizer alleged.

The court on December 14, 2022 held Triveni entities and their Director Kamlesh Singh guilty of contempt of the court’s order and on January 24, 2023 the Hon’ble Court directed them to pay Pfizer 2 crores within a period of two weeks, failing which, Singh would lodged in Tihar jail for two weeks.

“The court deems it appropriate to dispose of this application by directing Kamlesh Singh, the director of Defendants 1 and 2 to pay, to the plaintiff, an amount of Rs 2,00,00,000/- within a period of two weeks from today, failing which he shall be taken into custody and detained in a civil prison for a period of two weeks at Tihar Jail, Delhi,” the order said.

RECENT NEWS

HSBC Swings The Axe At UK Wealth In An AI Push

HSBC is preparing deep job cuts across its UK wealth management arm. It plans to cut about half of its management and sp... Read more

Kraken's Owner Buys A Bank: The Lines Are Blurring

Payward, the parent company of the crypto exchange Kraken, has agreed to buy a European bank. It would be the first digi... Read more

Revoluts Australian Banking Licence Game Changer

Revolut has spent much of its life insisting that it is more than a bank. In Australia, it has now decided that becoming... Read more

The AI Bank Is Coming, But Who Controls The Risk?

Artificial intelligence is no longer something banks discuss as a distant possibility. It is already working behind the ... Read more

ClearBank UK Profit Leads To European Growth

ClearBank has spent much of the past decade building the technology and regulatory infrastructure needed to challenge so... Read more

Bank Of London Continues To Rebuild

ClearBank’s progress shows that modern clearing and banking infrastructure can become a sizeable and profitable busine... Read more